Drug intelligence / Profile preview

CANVAC DHP

Development stage
Unknown
Lead developer
Dyntec
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

CANVAC DHP is a live attenuated trivalent veterinary vaccine developed by Dyntec for the active immunization of dogs. It is designed to protect against three major canine viral diseases: Canine Distemper, Infectious Hepatitis (caused by Canine Adenovirus Type 1), and Canine Parvovirus. The vaccine contains attenuated strains of the Canine Distemper Virus (CDV), Canine Adenovirus (CAV-2, which provides cross-protection against CAV-1), and Canine Parvovirus (CPV). Upon subcutaneous administration, the vaccine stimulates the dog's immune system to produce a protective response, preventing clinical signs and mortality associated with these pathogens. It is typically used in puppies and adult dogs as part of a core vaccination schedule.

Brand names
CANVAC DHP
Other names
CANVAC DHP
02

Targets

CAdV-2 (Canine adenovirus type 2)CDV (Canine distemper virus)

Beyond the preview

Go deeper on CANVAC DHP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CANVAC DHP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call